| Reaction Details |
|---|
 | Report a problem with these data |
| Target | C-C chemokine receptor type 5 |
|---|
| Ligand | BDBM50276291 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_540889 (CHEMBL1026563) |
|---|
| IC50 | 0.5±n/a nM |
|---|
| Citation |  Pryde, DC; Corless, M; Fenwick, DR; Mason, HJ; Stammen, BC; Stephenson, PT; Ellis, D; Bachelor, D; Gordon, D; Barber, CG; Wood, A; Middleton, DS; Blakemore, DC; Parsons, GC; Eastwood, R; Platts, MY; Statham, K; Paradowski, KA; Burt, C; Klute, W The design and discovery of novel amide CCR5 antagonists. Bioorg Med Chem Lett19:1084-8 (2009) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| C-C chemokine receptor type 5 |
|---|
| Name: | C-C chemokine receptor type 5 |
|---|
| Synonyms: | C-C CKR-5 | C-C chemokine receptor type 5 | CC-CKR-5 | CCR-5 | CCR5 | CCR5/mu opioid receptor complex | CCR5_HUMAN | CD_antigen=CD195 | CHEMR13 | CMKBR5 | HIV-1 fusion coreceptor |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 40540.21 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P51681 |
|---|
| Residue: | 352 |
|---|
| Sequence: | MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKR
LKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFII
LLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSS
HFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTI
MIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFV
GEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
|
|
|
|---|
| BDBM50276291 |
|---|
| n/a |
|---|
| Name | BDBM50276291 |
|---|
| Synonyms: | CHEMBL472464 | N-benzyl-N-(1'-(2,6-dimethylbenzoyl)-4'-methyl-1,4'-bipiperidin-4-yl)cyclopropanecarboxamide |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C31H41N3O2 |
|---|
| Mol. Mass. | 487.6761 |
|---|
| SMILES | Cc1cccc(C)c1C(=O)N1CCC(C)(CC1)N1CCC(CC1)N(Cc1ccccc1)C(=O)C1CC1 |
|---|
| Structure | 
|
|---|
Search and Browse
